Owing to simplicity in terms quantification and low cost of plasma albumin determination, it could substitute CD4+ and viral load tests (Graham et al. [2007], Kannangai et al. [2008]) as a prognostic marker during care for HIV and co morbidities such as TB. The gene discussed is CD4; the disease is tuberculosis.